Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug repurposing for antimicrobial discovery
Maya A. Farha, Eric D. Brown
Nature Microbiology (2019) Vol. 4, Iss. 4, pp. 565-577
Closed Access | Times Cited: 304

Showing 1-25 of 304 citing articles:

Structure of Mprofrom COVID-19 virus and discovery of its inhibitors
Zhenming Jin, Xiaoyu Du, Yechun Xu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 177
Drug repositioning: Progress and challenges in drug discovery for various diseases
Yi Hua, Xiaowen Dai, Yuan Xu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114239-114239
Open Access | Times Cited: 126
Supramolecular Photothermal Cascade Nano‐Reactor Enables Photothermal Effect, Cascade Reaction, and In Situ Hydrogelation for Biofilm‐Associated Tooth‐Extraction Wound Healing
Lei Chen, Mengna Peng, Jianan Zhou, et al.
Advanced Materials (2023) Vol. 35, Iss. 31
Closed Access | Times Cited: 82
Combination Therapies for Biofilm Inhibition and Eradication: A Comparative Review of Laboratory and Preclinical Studies
Sophia Hawas, Anthony D. Verderosa, Makrina Totsika
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 78
Resistance-proof antimicrobial drug discovery to combat global antimicrobial resistance threat
Aditya Upadhayay, Jingjing Ling, Dharm Pal, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100890-100890
Closed Access | Times Cited: 75
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal
Antonio Tarín-Pelló, Beatriz Suay‐García, María Teresa Pérez‐Gracia
Expert Review of Anti-infective Therapy (2022) Vol. 20, Iss. 8, pp. 1095-1108
Open Access | Times Cited: 71
Antimicrobial Hybrid Amphiphile via Dynamic Covalent Bonds Enables Bacterial Biofilm Dispersal and Bacteria Eradication
Yizhou Zhan, Xiaowen Hu, Yuanfeng Li, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 23
Closed Access | Times Cited: 52
Antimicrobial Hydrogels: Potential Materials for Medical Application
Yanni Li, Yujia Han, Hongxia Li, et al.
Small (2023) Vol. 20, Iss. 5
Open Access | Times Cited: 49
Antimicrobial resistance crisis: could artificial intelligence be the solution?
Guangyu Liu, Dan Yu, Mei-Mei Fan, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Insect Derived Lauric Acid as Promising Alternative Strategy to Antibiotics in the Antimicrobial Resistance Scenario
Luca Borrelli, Lorena Varriale, Ludovico Dipineto, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 97
Antimicrobial Activity of Curcumin in Nanoformulations: A Comprehensive Review
Jeffersson Krishan Trigo-Gutierrez, Yuliana Vega-Chacón, Amanda Brandão Soares, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7130-7130
Open Access | Times Cited: 95
Cyanobacteria and Eukaryotic Microalgae as Emerging Sources of Antibacterial Peptides
Verónica Rojas, Luís Rivas, Constanza Cárdenas, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5804-5804
Open Access | Times Cited: 88
Drug targets for COVID-19 therapeutics: Ongoing global efforts
Ambrish Saxena
Journal of Biosciences (2020) Vol. 45, Iss. 1
Open Access | Times Cited: 80
PepVAE: Variational Autoencoder Framework for Antimicrobial Peptide Generation and Activity Prediction
Scott N. Dean, Jerome Anthony E. Alvarez, Dan Zabetakis, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 78
The future of antibiotics begins with discovering new combinations
Meilin Zhu, Megan W. Tse, Juliane Weller, et al.
Annals of the New York Academy of Sciences (2021) Vol. 1496, Iss. 1, pp. 82-96
Open Access | Times Cited: 58
Heavy-Metal Trojan Horse: Enterobactin-Directed Delivery of Platinum(IV) Prodrugs toEscherichia coli
Chuchu Guo, Elizabeth M. Nolan
Journal of the American Chemical Society (2022) Vol. 144, Iss. 28, pp. 12756-12768
Open Access | Times Cited: 45
Two‐Tailed Dynamic Covalent Amphiphile Combats Bacterial Biofilms
Xiaowen Hu, Yuanfeng Li, Yinzi Piao, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 40
New antifungal strategies: Drug combination and co-delivery
Ping Zhu, Yan Li, Ting Guo, et al.
Advanced Drug Delivery Reviews (2023) Vol. 198, pp. 114874-114874
Closed Access | Times Cited: 29
Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications
Hao He, Hongrui Duo, Youjin Hao, et al.
Computers in Biology and Medicine (2023) Vol. 155, pp. 106671-106671
Closed Access | Times Cited: 23
Quorum Sensing Inhibitors: An Alternative Strategy to Win the Battle against Multidrug-Resistant (MDR) Bacteria
‏Helal F. Hetta, Yasmin N. Ramadan, Zainab I. Rashed, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3466-3466
Open Access | Times Cited: 12
Antibiotics: From Mechanism of Action to Resistance and Beyond
Shyamalima Saikia, Pankaj Chetia
Indian Journal of Microbiology (2024) Vol. 64, Iss. 3, pp. 821-845
Closed Access | Times Cited: 11
Industry 4.0 technologies adoption for digital transition in drug discovery and development: A review
Amit Anthwal, Akshat Uniyal, Jitender Gairolla, et al.
Journal of Industrial Information Integration (2024) Vol. 38, pp. 100562-100562
Closed Access | Times Cited: 10
Drug Repurposing in the Chemotherapy of Infectious Diseases
Amal Hamid, Pascal Mäser, Abdelhalim Babiker Mahmoud
Molecules (2024) Vol. 29, Iss. 3, pp. 635-635
Open Access | Times Cited: 8
Repurposing Mitomycin C in Combination with Pentamidine or Gentamicin to Treat Infections with Multi-Drug-Resistant (MDR) Pseudomonas aeruginosa
Elin Svedholm, Benjamin Bruce, Benjamin J. Parcell, et al.
Antibiotics (2024) Vol. 13, Iss. 2, pp. 177-177
Open Access | Times Cited: 8
Selective Serotonin Reuptake Inhibitors: Antimicrobial Activity Against ESKAPEE Bacteria and Mechanisms of Action
Thiago Hideo Endo, Mariana Homem de Mello Santos, Sara Scandorieiro, et al.
Antibiotics (2025) Vol. 14, Iss. 1, pp. 51-51
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top